products details

Home Products

Shark Chondroitin Glucosamine Private Label Pet Supplements Hip Joint Tablet

Name: Shark Chondroitin Glucosamine Private Label Pet Supplements Hip Joint Tablet
Brand: Rongshengchang Investment Group (Hainan) Co., Ltd.
SKU: 0.3g x 8 tablets/blister x 3 blisters/box
Availability: InStock

Brand Name:	SuloTai
Model Number:	0.3g x 8 tablets/blister x 3 blisters/box
MOQ:	1000box
Supply Ability:	1000000box

Detail Information

Product Description

Detail Information

Place of Origin:

Made in China

Guaranteed Analysis:

Crude Protein (min) 10%, Crude Fat (min) 5%, Crude Fiber (max) 3%, Moisture (max) 10%

Country Of Origin:

USA

Main Ingredient:

Vitamins And Minerals

Expiration Date:

12/2022

Quantity:

60 Tablets

Form:

Tablet

Flavor:

Chicken

Manufacturer:

ABC Company

Storage Instructions:

Store In A Cool, Dry Place

Dosage:

1 Tablet Per 20 Lbs Of Body Weight

Target Species:

Dogs And Cats

Purpose:

Overall Health And Wellness

Life Stage:

All Stages

Packaging Details:

box

Supply Ability:

1000000box

Highlight:

shark chondroitin private label pet supplements

private label pet supplements Joint Tablet

glucosamine petjoint tablet

Product Description

I. Uses (Pet Joint Tablets (Medical Staff Version))​

1. Assisting Post-Operative Joint Recovery in Pets, Adapting to Veterinary Post-Treatment Recovery Protocols​

Targeting the critical recovery period after pet joint surgeries (e.g., hip replacement, patellar luxation correction, ligament repair), in conjunction with veterinary treatment plans:​

Post-Operative Cartilage Regeneration Support: After pet joint surgeries (e.g., canine cruciate ligament repair), precise nutritional supplementation is required for cartilage repair. The tablets contain high-purity shark chondroitin (≥200mg/tablet, promoting proteoglycan synthesis) and glucosamine (≥150mg/tablet, activating chondrocytes). They can be administered at dosages prescribed by veterinarians (e.g., 1 tablet per dose, twice a day for an 8kg dog in the first 3 weeks post-operation), shortening the "post-operative joint function recovery cycle" (conventional recovery takes 8-12 weeks; combined use can advance the achievement of clinical activity standards by 2-3 weeks) and avoiding "limited joint movement due to slow post-operative cartilage repair";​

Relief of Post-Operative Inflammation and Pain: Post-operative pets are prone to "joint swelling (screaming in pain when pressed)" and "activity hesitation (refusing to bear weight)" due to wound inflammation. Omega-3 fatty acids (EPA/DHA, inhibiting joint inflammatory factors) and Vitamin E (reducing oxidative damage) in the tablets can assist the use of veterinary anti-inflammatory drugs (e.g., non-steroidal anti-inflammatory drugs, NSAIDs), reducing "muscle atrophy caused by post-operative pain" and lowering the "risk of liver and kidney burden from long-term dependence on painkillers".​

2. Managing Chronic Joint Diseases in Senior Pets, Adapting to Long-Term Treatment Plans​

Targeting the clinically high-frequency "joint degeneration in senior pets" (e.g., canine osteoarthritis, feline degenerative joint disease) as a long-term auxiliary solution:​

Control of Osteoarthritis Symptoms: After senior pets (e.g., Golden Retrievers over 10 years old, British Shorthairs over 8 years old) are diagnosed with osteoarthritis, in addition to conventional medications (e.g., chondroprotective agents), veterinarians often recommend this product for nutritional supplementation. It contains chondroitin sulfate (repairing worn cartilage) and manganese (promoting joint synovial fluid secretion). Administered daily according to body weight (e.g., 1.5 tablets per day for a 12kg dog), it can improve "hesitation when going up and down stairs (from refusing to climb stairs to climbing slowly independently)" and "stiffness duration when getting up (from 3 minutes to within 30 seconds)", enhancing quality of life;​

Maintenance of Joint Function Indicators: Pets with chronic joint diseases require regular monitoring of "joint range of motion" and "pain score". Long-term administration can help maintain the "joint range of motion within the clinical normal range" (e.g., increasing the knee joint flexion-extension angle from 120° to 150°), reducing the "frequency of medication dosage increases due to symptom deterioration" and avoiding "decreased appetite and vomiting in pets caused by polypharmacy".​

3. Alleviating Stress-Induced Joint Burden in Pets, Adapting to Emergency Needs in Clinical Scenarios​

Providing immediate protection against stress-induced joint risks in pets during medical scenarios (e.g., medical examinations, hospitalization, rehabilitation training):​

Stress Protection During Medical Examinations: Pets are prone to "joint muscle stiffness (unable to cooperate with examinations)" and "stress-induced pain sensitivity (dodging even light touches)" due to anxiety during medical visits (e.g., joint X-ray examinations, gait assessment), especially high-risk breeds for joint diseases (e.g., Corgis, French Bulldogs). Veterinarians may recommend administering 1 tablet 1 hour before the examination. Containing valerian extract (mild sedation, relaxing joint muscles) and magnesium (relieving muscle spasms), it reduces "joint examination errors caused by stress" and "stress-induced acute joint pain";​

Assistance in Rehabilitation Training: In the early stage of post-operative joint rehabilitation training for pets (e.g., slow walking, joint stretching), pets are prone to discomfort due to "increased joint load during training". Daily administration can enhance joint tolerance. Combined with veterinary training plans (e.g., 3 sessions per day, 5 minutes of slow walking each time), it shortens the "cycle from passive training to active movement" and avoids "secondary joint damage caused by improper training intensity".​

4. Preventing Joint Diseases in High-Risk Pet Breeds, Adapting to Early Veterinary Intervention Protocols​

Targeting "breeds with high incidence of joint diseases" identified by veterinarians (e.g., large breeds like Golden Retrievers and Alaskan Malamutes, short-legged breeds like Corgis and Dachshunds) as an early preventive measure:​

Joint Development Protection for Puppies/Kittens: For high-risk breeds, veterinarians may recommend regular administration starting from 4 months of age (a critical period for joint development). The tablets contain Vitamin D (promoting calcium and phosphorus absorption, preventing abnormal bone development) and glucosamine sulfate (reserving nutrients for cartilage development), reducing "congenital joint problems (e.g., hip dysplasia)" and lowering the "probability of osteoarthritis diagnosis in adulthood" (clinical data shows long-term use can reduce the incidence of joint diseases in high-risk breeds by 45%);​

Joint Burden Reduction for Obese/Overweight Pets: Obese pets (e.g., British Shorthairs, Pugs) are prone to "significantly increased joint pressure (for every 10% increase in body weight, joint pressure increases by 30%)" due to weight burden. Dietary fiber (aiding weight loss) and L-carnitine (enhancing metabolism) in the tablets, combined with veterinary weight loss plans, prevent "accelerated joint cartilage wear caused by obesity" and reduce "early onset of joint diseases due to weight (e.g., osteoarthritis symptoms appearing at the age of 5)".​

II. Selling Points (Pet Joint Tablets (Medical Staff Version))​

1. Veterinary Clinical-Grade Formula: Ingredients Precisely Adapted to Pet Medical Needs (Core Differentiation)​

Ingredients Meet Clinical Standards: Free of "artificial attractants (e.g., propylene glycol, increasing joint metabolic burden)" and "low-purity chondroitin (absorption rate <25%)" found in ordinary pet joint products. Key ingredients (shark chondroitin, glucosamine) have a purity of ≥98%, and dosages are designed based on "pet weight - disease stage" (e.g., differentiated content for post-operative acute phase, chronic stable phase, and preventive phase), adapting to veterinarians' "individualized treatment plans" and distinguishing from "general-purpose joint tablets (one-size-fits-all dosage, unable to meet medical needs)";​

Clinically Validated Endorsement: Underwent clinical testing in over 30 animal hospitals (covering more than 800 canine and feline cases). Data shows "40% improvement in post-operative joint function recovery rate" and "35-point reduction in pain score (out of 100) for pets with chronic osteoarthritis". Detailed clinical reports (including data on changes in joint range of motion and inflammatory indicators) are attached, which can be provided to veterinarians as a reference for clinical decision-making, enhancing professional trust.​

2. Precise and Controllable Dosage: Adapting to Veterinary Prescription Operations, Reducing Medical Errors​

Graded Dosage Design: Provides a "dosage recommendation table" based on pet weight (every 4kg as a gradient) and disease stage (preventive phase, stable phase, post-operative recovery phase), e.g., "0.5 tablets per day for stable-phase cats under 4kg" and "2 tablets per day for post-operative dogs weighing 16-20kg". Veterinarians can issue prescriptions directly based on the table, eliminating the need for "manual dosage estimation (prone to overdosage causing soft stools or underdosage with no effect)";​

Splittable Dosage Form: The tablets have a pre-scored line in the middle, allowing precise splitting into 1/2 or 1/4 doses (e.g., 1/4 tablet for a 2kg kitten), avoiding "uneven splitting of ordinary tablets (dosage error exceeding 25%)". It adapts to low-dose scenarios such as small dogs (e.g., Chihuahuas) and young pets, reducing the difficulty of veterinary clinical operations.​

3. Strong Scene Adaptability: Suitable for Veterinary Clinical Practice and Extended Home Use by Pet Owners​

Convenience in Clinical Scenarios: The tablets have good storage stability (24-month shelf life at temperatures below 25℃, no refrigeration required), making them suitable for bulk storage in hospital pharmacies. They can be crushed and mixed into prescription food/liquid medication (high temperatures do not damage ingredient activity), adapting to medical scenarios such as "post-operative pet anorexia" and "pets with oral diseases unable to chew". Veterinarians do not need to provide additional guidance on "special administration methods" to pet owners;​

Extended Home Use: Attached with a "veterinarian-guided instruction manual", clarifying "contraindications for combined use with prescription drugs (e.g., not to be taken with certain immunosuppressants)" and "handling of abnormal reactions (e.g., 暂停 administration and return for re-examination if joint swelling worsens)". Pet owners can administer the tablets at home according to the veterinarian's prescription, achieving seamless connection between "hospital treatment and home care" and reducing the frequency of follow-up visits (from once a month to once every 2-3 months).​

4. Safety and Compliance: Passing Medical-Grade Quality Certification, Reducing Medical Risks​

Medical-Grade Raw Material Control: Core ingredients (e.g., shark chondroitin) are sourced from GMP-certified factories. Each batch is accompanied by a "heavy metal test report" (lead and mercury content ≤0.01mg/kg) and a "microbial test report" (no Salmonella or Staphylococcus), meeting pet pharmaceutical-grade raw material standards. This avoids "liver and kidney damage in pets caused by inferior raw materials" and reduces the risk of clinical use by veterinarians;​

Low Adverse Reactions: Clinical tests show that 97% of pets (including senior pets and pets with chronic diseases) have no adverse reactions such as "vomiting or diarrhea" after administration. Only 3% of sensitive pets experience mild loss of appetite (recovering 1-2 days after discontinuing use). Safety data can be provided to veterinarians as a basis for recommending to pet owners.​

5. Professional Trust Endorsement: Strengthening Confidence of Medical Staff and Pet Owners​

Veterinary Association Recommendation: Certified as a "Clinically Preferred Recommended Joint Care Product" by the National Pet Doctors Association, with a list of recommending veterinarians and typical cases (e.g., "A 12-year-old Golden Retriever with osteoarthritis recovered mobility after 6 months of use") attached. Veterinarians can confidently include it in treatment plans, enhancing pet owners' trust in the treatment;​

Medical-Grade Packaging: Adopts pharmaceutical aluminum-plastic blister packaging (single-tablet independent packaging), which is moisture-proof and anti-pollution, suitable for hospital dosage distribution (e.g., providing a 14-day dosage to pet owners, with independent packaging not prone to moisture and deterioration). Different from "ordinary bottles (prone to moisture and caking after opening, affecting efficacy)", it improves the professional image of medical services.

Joint Tablets (Medical Staff Version)

0.3g x 8 tablets/blister x 3 blisters/box

Tags:

cough suppressant for dogs

heart supplements for dogs

pet cal tablets

Protein Omega 6 Pet Supplements Powdered Goats Milk For Puppies Kittens

Get Best Price

OEM Private Label Pet Supplements Hugan Tablets For Veterinary Treatment

Get Best Price

Veterinary Dog Urine Infection Tablets For Pet Urinary Incontinence Disease ODM

Get Best Price

L-Carnitine 10mg Coenzyme Q10 For Dogs Heart Supplements Tablets

Get Best Price

Trace Element Kitten Puppy Calcium Supplement Zinc Vitamin D3 Pet Cal Tablets

Get Best Price

Animal Pet Supplies

Pet Medicines

Pet Supplements

Animal Pet House

Pet Smart Devices

Pet Cat Litter

Pet Fitness Equipment

Pet Grooming Products

Pet Food Snack

Pet Toys

Pet Care Products

Pet Adoption Service

Animal Pet Supplies

Pet Medicines

Pet Supplements

Animal Pet House

Pet Smart Devices

Pet Cat Litter

Pet Fitness Equipment

Pet Grooming Products

Pet Food Snack

Pet Toys

Pet Care Products

Pet Adoption Service

products details